Literature DB >> 33858453

Video-assisted pulmonary metastectomy is equivalent to thoracotomy regarding resection status and survival.

Till Markowiak1, Beshir Dakkak1, Elena Loch1, Christian Großer2, Monika Klinkhammer-Schalke3, Hans-Stefan Hofmann1,2, Michael Ried4.   

Abstract

BACKGROUND: Surgical resection of pulmonary metastases leads to prolonged survival if strictly indicated. Usually, thoracotomy with manual palpation of the entire lung with lymph node dissection or sampling is performed. The aim of this study was to evaluate the role of video-assisted thoracoscopic surgery (VATS) in pulmonary metastectomy with curative intent.
METHODS: In this study, all patients with suspected pulmonary metastasis (n = 483) who visited the Center for Thoracic Surgery in Regensburg, between January 2009 and December 2017 were analysed retrospectively.
RESULTS: A total of 251 patients underwent metastectomy with curative intent. VATS was performed in 63 (25.1%) patients, 54 (85.7%) of whom had a solitary metastasis. Wedge resection was the most performed procedure in patients treated with VATS (82.5%, n = 52) and thoracotomy (72.3%, n = 136). Postoperative revisions were necessary in nine patients (4.8%), and one patient died of pulmonary embolism after thoracotomy (0.5%). Patients were discharged significantly faster after VATS than after thoracotomy (p < 0.001). Complete (R0) resection was achieved in 89% of patients. The median recurrence-free survival was 11 months (95% confidence interval 7.9-14.1). During follow-up, eight (12.7%) patients in the VATS group and 42 (22.3%) patients in the thoracotomy group experienced recurrence (p = 0.98). The median overall survival was 61 months (95% confidence interval 46.1-75.9), and there was no significant difference with regard to the surgical method used (p = 0.34).
CONCLUSIONS: VATS metastasectomy can be considered in patients with a solitary lung metastasis. An open surgical approach with palpation of the lung showed no advantage in terms of surgical outcome or survival.

Entities:  

Keywords:  Lung metastases; Metastectomy; Prognosis; Pulmonary metastases; Video-assisted thoracoscopic surgery

Year:  2021        PMID: 33858453     DOI: 10.1186/s13019-021-01460-8

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


  30 in total

1.  THE SURGICAL TREATMENT OF METASTATIC TUMORS IN THE LUNGS.

Authors:  N R THOMFORD; L B WOOLNER; O T CLAGETT
Journal:  J Thorac Cardiovasc Surg       Date:  1965-03       Impact factor: 5.209

2.  When professional opinion is not enough.

Authors:  Tom Treasure; Martin Utley; Ian Hunt
Journal:  BMJ       Date:  2007-04-21

3.  Evaluation of a new prognostic score (Munich score) to predict long-term survival after resection of pulmonary renal cell carcinoma metastases.

Authors:  Georgios Meimarakis; Martin Angele; Michael Staehler; Dirk-Andre Clevert; Alexander Crispin; Dominik Rüttinger; Florian Löhe; Gerhard Preissler; Rudolf A Hatz; Hauke Winter
Journal:  Am J Surg       Date:  2011-08       Impact factor: 2.565

4.  Pulmonary metastasectomy in patients with renal cell carcinoma: a single-institution experience.

Authors:  Atsunari Kawashima; Masashi Nakayama; Daizo Oka; Mototaka Sato; Koji Hatano; Masatoshi Mukai; Akira Nagahara; Yasutomo Nakai; Hitoshi Takayama; Masayoshi Inoue; Hiroyuki Shiono; Kazuo Nishimura; Meinoshin Okumura; Norio Nonomura
Journal:  Int J Clin Oncol       Date:  2011-05-10       Impact factor: 3.402

5.  Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer.

Authors:  Stefan Welter; Jan Jacobs; Thomas Krbek; Christoph Poettgen; Georgios Stamatis
Journal:  Eur J Cardiothorac Surg       Date:  2006-12-05       Impact factor: 4.191

Review 6.  Surgical intervention for pulmonary metastases.

Authors:  Joachim Pfannschmidt; Gerlinde Egerer; Marc Bischof; Michael Thomas; Hendrik Dienemann
Journal:  Dtsch Arztebl Int       Date:  2012-10-05       Impact factor: 5.594

Review 7.  Pulmonary metastasectomy: an overview.

Authors:  Francesco Petrella; Cristina Diotti; Arianna Rimessi; Lorenzo Spaggiari
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

8.  Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer.

Authors:  K Watanabe; K Nagai; A Kobayashi; M Sugito; N Saito
Journal:  Br J Surg       Date:  2009-09       Impact factor: 6.939

9.  The prognostic importance of the number of metastases in pulmonary metastasectomy of colorectal cancer.

Authors:  Jong Ho Cho; Seok Kim; Mi Namgung; Yong Soo Choi; Hong Kwan Kim; Jae Ill Zo; Young Mog Shim; Jhingook Kim
Journal:  World J Surg Oncol       Date:  2015-07-25       Impact factor: 2.754

10.  Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial.

Authors:  Tom Treasure; Vern Farewell; Fergus Macbeth; Kathryn Monson; Norman R Williams; Chris Brew-Graves; Belinda Lees; Olivia Grigg; Lesley Fallowfield
Journal:  Trials       Date:  2019-12-12       Impact factor: 2.279

View more
  2 in total

1.  Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) randomized controlled trial: a systematic review of published responses.

Authors:  Norman R Williams; Hannah Patrick; Francesca Fiorentino; Alexander Allen; Manuj Sharma; Mišel Milošević; Fergus Macbeth; Tom Treasure
Journal:  Eur J Cardiothorac Surg       Date:  2022-06-15       Impact factor: 4.534

2.  The full cohort of 512 patients and the nested controlled trial in 93 patients in the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) study raise doubts about the effective size at present claimed.

Authors:  Tom Treasure; Norman R Williams; Fergus Macbeth
Journal:  J Cardiothorac Surg       Date:  2022-01-16       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.